Wednesday, July 8, 2026

pharma · Metastatic castration-resistant prostate cancer. · short-term treatment of insomnia

Orion Laboratories Pty

Orion Laboratories Pty clinical programs — 3 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.

Baton Rouge, USA HQ
2008 Founded
52 Employees
TGA registrant Type
Company details
Status
Public
HQ
Baton Rouge, USA
Founded
2008
Employees
52
Programs
9
Drugs
20
Patents
0
Intelligence · Clinical Programs

Orion Laboratories Pty projects

3 ClinicalTrials.gov programs sponsored by Orion Laboratories Pty.

Orion Laboratories Pty has 3 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.

Clinical programs

  1. 3135003

    Orion Laboratories Pty.

    Parkinson desease

    phase 1 other active

    1 trial
  2. 3135004

    Orion Laboratories Pty.

    Parkinson disease

    phase 1 other active

    1 trial
  3. 3137001

    Orion Laboratories Pty.

    short-term treatment of insomnia

    phase 1 other active

    1 trial

Frequently asked questions

How many clinical projects does Orion Laboratories Pty have?

3 published programs are linked to this sponsor in our ClinicalTrials.gov index.

Is this the complete company pipeline?

This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.